Samsung Bioepis NL B.V. Operating company Corporate group: Samsung Group · HQ: South Korea
Not counted above: 2 file-access requests (R. 262.1(b) RoP), where someone asked to read a case file. View
Samsung Bioepis NL B.V. has been party to eight Unified Patent Court cases, 6 times as claimant and twice as respondent. The most recent on record is UPC CoA 152/2026 at the Court of Appeal, brought by Carpmaels & Ransford LLP.
Alexion Pharmaceuticals, Inc. 8
2026-09-15 UPC CoA 152/2026 Court of Appeal File-access request Carpmaels & Ransford LLP v Samsung Bioepis NL B.V. 2025-08-14 UPC CoA 750/2025 Court of Appeal Withdrawn Samsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc. 2025-08-13 UPC CoA 744/2025 Court of Appeal Withdrawn Samsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc. 2025-07-22 UPC CFI 674/2025 Hamburg LD — Samsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc. 2025-01-23 UPC CFI 51/2025 Hamburg LD — Samsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc. 2025-01-22 UPC CFI 40/2025 Hamburg LD Costs only Samsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc. 2024-11-08 UPC APP 60271/2024 Hamburg LD File-access request Name not displayed for GDPR reasons. Represented by Jochen HÖHFELD v Alexion Pharmaceuticals, Inc. 2024-07-26 UPC APP 43786/2024 Hamburg LD Costs only Samsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc. 2024-07-11 UPC CoA 402/2024 Court of Appeal PI refused Alexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V. 2024-03-19 UPC CFI 123/2024 Hamburg LD PI refused Alexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V.